AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Euroglip-M 2mg/500mg Tablet

Prescription Icon
Prescription Required

Marketer

Solitaire Pharmacia Pvt Ltd

Salt Composition

Glimepiride (2mg) + Metformin (500mg)

Overview Euroglip-M 2mg/500mg Tablet

Glipizide-Metformin 2mg/500mg tablets are classified as antidiabetic medications. This dual-action formulation treats type 2 diabetes in adults by regulating blood glucose. Administer this medication with food, consistently at the same time daily for optimal efficacy. Dosage is determined and adjusted by your physician based on your blood sugar response. Continued use is crucial, even with controlled blood sugar, as discontinuation without medical supervision risks elevated glucose levels, potentially leading to kidney complications, vision impairment, neuropathy, and limb loss. Remember, this medication complements a comprehensive diabetes management plan including diet, exercise, and weight management as directed by your doctor. Lifestyle modifications are vital for diabetes control. Hypoglycemia (low blood sugar) is a common side effect, characterized by sweating, dizziness, headache, and tremors. Learn to identify and manage these symptoms. Regular meals and readily available glucose sources (e.g., sugary foods, juice) are essential preventative measures. Alcohol consumption elevates hypoglycemia risk and should be limited. Additional potential side effects include altered taste, nausea, diarrhea, abdominal discomfort, headache, and upper respiratory infections. Weight gain may occur. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Individuals with a history of heart disease should inform their physician before commencing treatment. Consult your doctor before use during pregnancy or breastfeeding. Regular blood glucose monitoring, along with periodic blood tests to assess blood cell counts and liver function, are recommended.

Primary Ingredients of Euroglip-M 2mg/500mg Tablet

No text provided to rephrase.

Uses of Euroglip-M 2mg/500mg Tablet

Managing type 2 diabetes

Major Benefits of Euroglip-M 2mg/500mg Tablet:

Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment schedule. Ingest the Euroglip-M 2mg/500mg tablet whole; avoid chewing, crushing, or fracturing it. It should be administered with a meal.

Common Side effects of Euroglip-M 2mg/500mg Tablet:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Euroglip-M 2mg/500mg Tablet:

Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. The Euroglip-M 2mg/500mg tablet should be administered with a meal.

How Euroglip-M 2mg/500mg Tablet works:

Each Euroglip-M 2mg/500mg tablet combines glimepiride (a sulfonylurea) and metformin (a biguanide), two medications that manage blood sugar. Glimepiride stimulates the pancreas to release more insulin, thus reducing blood glucose. Metformin acts by decreasing liver glucose production, slowing intestinal glucose absorption, and enhancing insulin responsiveness throughout the body.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Euroglip-M 2mg/500mg tablets with alcohol is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Euroglip-M 2mg/500mg tablets during pregnancy may pose risks. While human research is scant, animal studies indicate potential harm to the fetus. A physician will assess the potential advantages against the risks prior to prescribing. Seek medical advice before taking this medication.

Breast feedingBreast feedingUNSAFE

Breastfeeding mothers should avoid Euroglip-M 2mg/500mg tablets. Evidence indicates potential infant harm from this medication.

DrivingDrivingCAUTION

Driving may be impaired by excessively low or high blood glucose levels. Refrain from driving if such symptoms arise.

KidneyKidneyCAUTION

Patients with kidney impairment should use Euroglip-M 2mg/500mg tablets cautiously, potentially requiring dosage modification. Severe kidney disease contraindicates the use of Euroglip-M 2mg/500mg tablets. Physician consultation is essential. Regular kidney function assessments are recommended during treatment.

LiverLiverCAUTION

Individuals with liver impairment should use Euroglip-M 2mg/500mg tablets cautiously. Dosage modifications may be necessary. Physician consultation is advised. For those with mild to moderate liver disease, a low initial dose of Euroglip-M 2mg/500mg tablets is typically recommended; however, its use is contraindicated in patients with severe liver disease.

What if you forget to take Euroglip-M 2mg/500mg Tablet :

Should you forget a dose of Euroglip-M 2mg/500mg Tablet, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Euroglip-M 2mg/500mg Tablet

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Euroglip-M 2mg/500mg Tablet

Store this medication in its original, tightly closed container, as directed on the label or packaging. Discard any unused medication and ensure it's inaccessible to children, pets, and others.
Euroglip-M 2mg/500mg Tablets can cause lactic acidosis, a serious medical emergency (also known as MALA, or Metformin-associated lactic acidosis) resulting from excessive blood lactic acid. This rare but potentially harmful side effect is more likely in patients with kidney disease, older adults, or those who consume large amounts of alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue use and seek immediate medical attention.
Euroglip-M 2mg/500mg tablets combine glimepiride and metformin to manage type 2 diabetes mellitus in adults. This combination improves blood glucose control when used with diet and exercise. Glimepiride stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. It is not suitable for type 1 diabetes.
Euroglip-M 2mg/500mg tablets may cause common side effects including hypoglycemia, taste changes, nausea, stomach pain, diarrhea, and headache. Rare but serious side effects such as lactic acidosis are also possible. Prolonged use may result in vitamin B12 deficiency.
Prolonged use of Euroglip-M 2mg/500mg tablets can lead to vitamin B12 deficiency by hindering its absorption. This deficiency, if left untreated, may result in anemia, neurological issues such as tingling, numbness in extremities, weakness, urinary problems, cognitive changes, and ataxia. To mitigate this risk, supplemental vitamin B12 is recommended annually by some researchers.
Euroglip-M 2mg/500mg Tablets can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heart rate, anxiety, or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other antidiabetic medications. Regular blood sugar monitoring is crucial. Carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice, at all times.
Combining Euroglip-M 2mg/500mg tablets with alcohol is unsafe. Alcohol can exacerbate the drug's effect, potentially causing dangerously low blood sugar (hypoglycemia) and increasing the risk of lactic acidosis.
Euroglip-M 2mg/500mg Tabl...
40
MRP 49
18% off